Objective: The purpose of this study was to evaluate the benefits achievable by Amplicor polymerase chain reaction (PCR) (F. Hoffmann-LaRoche Ltd., Basel, Switzerland) with urine specimens in addition to PACE 2 (Gen-Probe, Inc., San Diego, California) assay with cervical swab specimens in the diagnosis of Chlamydia trachomatis in women.
Studies on the use of PCR with male urine specimens have demonstrated an enhanced sensitivity compared to that achieved by conventional chlamydial cell culture with urethral swab specimens. " '4 Recently, PCR with urine specimens has been applied for the diagnosis of C. trachomatis infection in women. 7 ,s These studies have suggested urine as a superior sample material for the detection of C. trachomatis also in women, and this finding has been explained by the fact that a proportion of female C. trachomatis infections can only be detected in the urethra. In our previous study, the presence of DNA polymerase inhibitors in 15% of female urine specimens proved to be an unexpectedly frequent threat to the performance of PCR, 8 but in other studies in different patient populations the frequency of inhibitory specimens has varied considerably, or they have not especially been searched for.
In the present study, we aimed to determine the benefit achievable by the Amplicor PCR with urine specimens in addition to PACE 2 hybridization assay with cervical specimens. Special attention was given to detecting the inhibitory urine specimens in order to evaluate the actual significance of DNA polymerase inhibitors on the sensitivity of the PCR.
SUBJECTS AND METHODS
The study population When the prepared urine specimens were diluted 1:10 for the PCR, 4 of the 5 PCR-negative specimens from PACE 2-positive patients turned positive by the PCR, indicating the presence of PCR inhibitors. In contrast, 3 urine specimens from PACE 2-positive patients that were originally positive by the PCR turned negative when diluted, indicating a substantial loss of sensitivity by the additional dilution procedure.
When the total number of 29 chlamydial infections detected was regarded as the basis of calculation, the use of PCR with female urine specimens yielded a sensitivity of 82.8%. The sensitivity of PACE 2 assay with endocervical specimens was 89.7%. By using both diluted and undiluted urine specimens to eliminate PCR inhibition, the sensitivity of PCR with urine could be enhanced to 96.6%.
Amplicor PCR detected C. trachomatis in the urine specimens of 4 women that were negative by PACE 2 with cervical specimens. Three of these 4 were confirmed positive by MOMP-PCR. The confirmed chlamydial infections that could only be found in urine thus represent 10% of the total number of infections found in the present study.
DISCUSSION
Earlier studies have shown that urine is inappropriate for chlamydial isolation. 1 Various antigen detection tests, on the other hand, have been successfully applied for the detection of C. trachomatis infection in male urine with a sensitivity approximating that achieved by culturing urethral swab specimens.
11,2 The fact that similar testing of female urine did not approximate results achieved by culturing cervical swabs was explained by assuming that not all patients with endocervical infection had infected urethras. 12,1-In clinical practice, urethral sampling in females is frequently overlooked.
PCR on male urine specimens has been shown to be a highly sensitive and specific non-invasive technique for the diagnosis of C. trachomatis, providing an opportunity for the identification of both asymptomatic and symptomatic infected patients) , 4 According to recent studies, the amplification power of PCR appears to make possible the same approach in females as well. 7, 8 The presence of DNA polymerase inhibitors was first described in endocervical specimens, where the ensuing percentage of false negative results varied between 4% and 10% in different reports, depending on the prevalence of chlamydial
INFECTIOUS DISEASES IN OBSTE'IRICS AND GYNECOLOGY
infection in the population studied. 4 ,s PCR inhibitors were also found in male urine although they were first thought to occur less frequently than in endocervical specimens, i.e., in 0-3% of true positive specimens. 
